Flat Cell Variant of Lung Adenocarcinoma In Situ
Modern Pathology · 2025
DOI: 10.1016/j.modpat.2025.100876 ↗Kurz gefasst
Fachartikel in der Zeitschrift Modern Pathology, 2025. Verfasst von Naoyuki Oka und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Molecular Pathology, National Cancer Center Research Institute, Tokyo, Japan; Department of Thoracic Surgery, National Cancer Center Hosp…. Hauptthemen laut MEDLINE: Lung Neoplasms, Adenocarcinoma in Situ, Adenocarcinoma. Die Arbeit nennt 18 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science, Japan Society for the Promotion of Science London.
Abstract (Originalsprache)
Adenocarcinoma in situ (AIS) of the lungs has been increasingly diagnosed worldwide following the establishment of its diagnostic criteria along with advances in computed tomography imaging technology. We encountered a series of AISs with a peculiar flat cell morphology that were challenging to diagnose using the current diagnostic criteria. Histologically, all 5 tumors showed a lepidic pattern consisting of flat tumor cells with minimal nuclear atypia. Intra-alveolar mucin was identified in 4 cases, although cytoplasmic mucin of the tumor cells was inconspicuous. All tumors harbored genetic or immunohistochemical features of neoplasms identical to those of conventional AIS. Driver mutations were detected in 3 tumors (2 EGFR mutations and 1 ERBB2 mutation), and 4 tumors were positive for hepatocyte nuclear factor 4 alpha, although the intensity was very low. We also identified a flat cell variant of minimally invasive adenocarcinoma, suggesting a stepwise progression similar to that in conventional AIS. These findings suggest that AIS with flat cellular features is a morphologic variant of AIS and may be challenging to diagnose if pathologists are unaware of this atypical feature of lung neoplasm.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Molecular Pathology, National Cancer Center Research Institute, Tokyo, Japan; Department of Thoracic Surgery, National Cancer Center Hospital, Tokyo, Japan; Division of Thoracic Surgery, Department of Surger…
- Department of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan.
- Division of Molecular Pathology, National Cancer Center Research Institute, Tokyo, Japan; Department of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan.
- Department of Diagnostic Radiology, National Cancer Center Hospital, Tokyo, Japan.
- Division of Thoracic Surgery, Department of Surgery, Keio University School of Medicine, Tokyo, Japan.
- Department of Thoracic Surgery, National Cancer Center Hospital, Tokyo, Japan.
Förderung
- Japan Society for the Promotion of Science
- Japan Society for the Promotion of Science London
Zitieren
APA
Oka, N., Kishikawa, S., Kashima, J., Watanabe, H., Kusumoto, M., Asakura, K., Watanabe, S. I., & Yatabe, Y. (2025). Flat Cell Variant of Lung Adenocarcinoma In Situ. Modern Pathology. https://doi.org/10.1016/j.modpat.2025.100876
Vancouver
Oka N, Kishikawa S, Kashima J, Watanabe H, Kusumoto M, Asakura K, et al. Flat Cell Variant of Lung Adenocarcinoma In Situ. Modern Pathology. 2025. doi:10.1016/j.modpat.2025.100876
BibTeX
@article{Oka2025,
author = {Oka, Naoyuki and Kishikawa, Satsuki and Kashima, Jumpei and Watanabe, Hirokazu and Kusumoto, Masahiko and Asakura, Keisuke and Watanabe, Shun-Ichi and Yatabe, Yasushi},
title = {Flat Cell Variant of Lung Adenocarcinoma In Situ},
journal = {Modern Pathology},
year = {2025},
doi = {10.1016/j.modpat.2025.100876}
}
EUVIMED